Browse studies
Find your next paid study
40 recruiting studies matching your filters
Phase 2
Dose-response of Aerobic Training During Chemotherapy for Gastrointestinal Cancers
The purpose of this study is to find the level of aerobic exercise (AT) that is practical, is safe, and has positive effects on the body that may reduce the si…
Gastrointestinal Cancer
Memorial Sloan Kettering Cancer CenterNCT05789485
Phase 1
Phase I Dose-Escalating Study of Combining Intravenous Tirapazamine and Transarterial Embolization (TAE) in Liver Cancer
This phase 1 study is to determine the optimal dose and tolerability of a hypoxia-activating agent, tirapazamine, when it is combined with embolization in live…
Hepatocellular CarcinomaGastrointestinal Cancer MetastaticNeuroendocrine Tumors
Teclison Ltd.NCT02174549
Phase 1
A Platform Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
The purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON) inhibito…
Colorectal CancerCRCPancreatic Ductal Adenocarcinoma+3 more
Revolution Medicines, Inc.NCT06445062
Phase 1
Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
This is a Phase I study to evaluate the safety and tolerability of sacituzumab govitecan in combination with capecitabine for advanced gastrointestinal cancers…
Gastrointestinal Cancer
Henry Ford Health SystemNCT06065371